2Brogden RN,Goa KL, Coukll AJ. Related articles, links amphotericin--B colloidal dispersion. Areview of its use against systemic fungal infections and visceral leishmaniasis [J]. Drugs, 1998,56 (3) :365-366.
2Sarosi GA. Amphotericin B:still the ‘gold standard' for antifungal therapy[J]. Postgrad Med, 1990, 88: 151-152, 155-156, 165-166
3Grasela TH Jr, Goodwin SD, Walawander MK, et al. Prospective surveillance of intravenous amphotericin B use patterns[J]. Pharmacotherapy, 1990,10: 341-348
4Pathak A, Pien FD, Carvalho L. Amphotericin B use in a community hospital, with special emphasis on side effects[J]. Clin Infect Dis,1998, 26: 334-338
5Luber AD, Maa L, Lam M, et al. Risk factors for amphotericin B-induced nephrotoxicity[J]. J Antimicrob Chemoth,1999, 43: 267-271
